Reciprocal changes in renal ACE/ANG II and ACE2/ANG 1-7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats by Prieto, Minolfa C. et al.
Reciprocal changes in renal ACE/ANG II and ACE2/ANG 1–7 are associated
with enhanced collecting duct renin in Goldblatt hypertensive rats
Minolfa C. Prieto,1,2 Romer A. González-Villalobos,1,2 Fady T. Botros,1,2 Victoria L. Martin,1
Javier Pagán,2 Ryousuke Satou,2 Lucienne S. Lara,1,2,3 Yumei Feng,1 Fernanda B. Fernandes,4
Hiroyuki Kobori,1,2 Dulce E. Casarini,4 and L. Gabriel Navar1,2
1Department of Physiology and 2Hypertension and Renal Center, Tulane University Health Sciences Center, New Orleans,
Louisiana; 3Biomedical Sciences Institute, Federal University of Rio de Janeiro, Rio de Janeiro; and 4Nephrology Division,
Department of Medicine, Federal University of Sao Paulo, Sao Paulo, Brazil
Submitted 7 July 2009; accepted in final form 30 December 2010
Prieto MC, González-Villalobos RA, Botros FT, Martin VL,
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Casarini DE, Navar LG. Reciprocal changes in renal ACE/ANG
II and ACE2/ANG 1–7 are associated with enhanced collecting
duct renin in Goldblatt hypertensive rats. Am J Physiol Renal
Physiol 300: F749–F755, 2011. First published January 5, 2011;
doi:10.1152/ajprenal.00383.2009.—Alterations in the balance be-
tween ANG II/ACE and ANG 1–7/ACE2 in ANG II-dependent
hypertension could reduce the generation of ANG 1–7 and contribute
further to increased intrarenal ANG II. Upregulation of collecting duct
(CD) renin may lead to increased ANG II formation during ANG
II-dependent hypertension, thus contributing to this imbalance. We
measured ANG I, ANG II, and ANG 1–7 contents, angiotensin-
converting enzyme (ACE) and ACE2 gene expression, and renin
activity in the renal cortex and medulla in the clipped kidneys (CK)
and nonclipped kidneys (NCK) of 2K1C rats. After 3 wk of unilateral
renal clipping, systolic blood pressure and plasma renin activity
increased in 2K1C rats (n  11) compared with sham rats (n  9).
Renal medullary angiotensin peptide levels were increased in 2K1C
rats [ANG I: (CK  171  4; NCK  251  8 vs. sham  55  3
pg/g protein; P  0.05); ANG II: (CK  558  79; NCK  328 
18 vs. sham 94 7 pg/g protein; P 0.001)]; and ANG 1–7 levels
decreased (CK  18  2; NCK  19  2 pg/g vs. sham  63  10
pg/g; P  0.001). In renal medullas of both kidneys of 2K1C rats,
ACE mRNA levels and activity increased but ACE2 decreased. In
further studies, we compared renal ACE and ACE2 mRNA levels and
their activities from chronic ANG II-infused (n  6) and sham-
operated rats (n  5). Although the ACE mRNA levels did not differ
between ANG II rats and sham rats, the ANG II rats exhibited greater
ACE activity and reduced ACE2 mRNA levels and activity. Renal
medullary renin activity was similar in the CK and NCK of 2K1C rats
but higher compared with sham. Thus, the differential regulation of
ACE and ACE2 along with the upregulation of CD renin in both the
CK and NCK in 2K1C hypertensive rats indicates that they are
independent of perfusion pressure and contribute to the altered content
of intrarenal ANG II and ANG 1–7.
ANG II-dependent hypertension; angiotensin peptides; angiotensin-
converting enzyme; qRT-PCR; immunohistochemistry
IN ANGIOTENSIN II (ANG II)-dependent hypertension, increased
circulating ANG II levels lead to progressive augmentation of
intrarenal ANG II content (35, 57, 61). The increased intrarenal
ANG II content results from AT1 receptor (AT1R)-mediated
uptake of circulating ANG II, as well as de novo intrarenal
ANG II generation (52). Increased local ANG II formation has
been associated with augmentation of intrarenal angiotensino-
gen (AGT) synthesis and secretion by proximal tubule (PT)
cells (27, 29, 59) leading to augmented urinary AGT excretion
indicating that proximally secreted AGT traverses the distal
nephron segments (27, 30).
Renin, primarily synthesized and released by juxtaglomeru-
lar (JG) cells, is also produced by principal cells of connecting
tubules and collecting duct (CD) cells of rat, mouse, and
human kidneys (22, 42, 48). Previous studies suggest that
tubular renin is differentially regulated from renin in JG cells
(20, 37, 42, 43, 47). In response to chronic ANG II infusions,
renin mRNA and protein levels increase in principal cells from
connecting tubules and CD, indicating stimulation of tubular
renin during ANG II-dependent hypertension (42). This stim-
ulatory effect of CD renin is prevented by treatment with
AT1R blockers suggesting that it is mediated by an AT1R
mechanism (43). Studies showing augmentation of CD renin in
both clipped and unclipped kidneys of Goldblatt hypertensive
rats indicate that the enhanced CD renin occurs independently
of blood pressure (44). Thus, enhanced CD renin acting on
AGT delivered from proximal nephron segments may contrib-
ute to increased ANG I generation that can then be converted
to ANG II by the substantial angiotensin-converting enzyme
(ACE) activity present in the CD (4, 5).
ACE2, the homolog of ACE, is abundantly expressed in the
kidney and metabolizes ANG II to generate the heptapeptide
ANG 1–7 (10, 51, 53). ANG 1–7 may antagonize the actions of
ANG II especially in situations of an overactive renin-angio-
tensin system (RAS) (12, 13, 15, 51). Recent studies showed
decreased ACE2 mRNA expression in spontaneous hyperten-
sive rats and mRen2 hypertensive rats (7, 58). The decreased
ACE2 expression is associated with the onset and severity of
hypertension (53). ANG II has been shown to downregulate
ACE2 expression in astrocytes, heart, and kidney, suggesting
that during high-ANG II states, the generation of ANG 1–7
might be reduced (17–19). Alternatively, the reduced ACE2
expression might be due to the increased renal perfusion
pressure observed in these models. Goldblatt hypertensive rats
exhibit high intrarenal ANG II content in both kidneys, as well
as upregulation of renin in distal nephron segments that may
lead to regional differences in the content of intrarenal angio-
tensin peptides, as well as changes in the expression of ACE
and ACE2 within the kidneys. Accordingly, the present study
was performed to determine the regional changes in ANG
II/ACE and ANG 1–7/ACE2 in ANG II-dependent hyperten-
sion by using Goldblatt hypertensive rats and examining the
levels of ANG I, ANG II, and ANG 1–7, as well as ACE and
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ACE2 gene expression separately in renal cortical and medul-
lary tissues from both kidneys of 2K1C hypertensive rats after
3 wk of unilateral renal artery clipping. Additional studies were
performed in rats infused chronically with ANG II (80 ng/min)
for 2 wk. We hypothesized that, in 2K1C hypertensive rats, the
intrarenal contents of ANG 1–7 and ACE2 transcript levels are
decreased in both clipped and unclipped kidneys. These results
indicate that there is differential regulation of ACE/ACE2 in
renal tissues of 2K1C rats, which may help to explain the
reciprocal changes in ANG II and ANG 1–7 observed in the
kidneys of Goldblatt hypertensive rats and ANG II-infused
rats.
MATERIALS AND METHODS
Experimental animals, sample collections, and tissue preparation.
All protocols were approved by the Tulane University Health Sci-
ences Center Animal Care and Use Committee. Male Sprague-Dawley
rats (150 to 175 g; Charles River Laboratories, Wilmington, MA)
were anesthetized and a u-shaped silver clip (lumen diameter of 0.25
mm) was placed on the left renal artery (n  11), or the rats were just
subjected to a sham operation (n 9). Following a training period, the
systolic blood pressures (SBP) were measured by tail-cuff plethys-
mography (Visitech, BP-2000, Apex, NC) 1 day before placement of
the silver clip (lumen diameter of 0.25 mm) on the left renal artery,
and at the end of the first, second, and third weeks of the study. On day
25 after unilateral renal clipping, rats were euthanized by conscious
decapitation and trunk blood samples and kidneys were harvested; the
cortex and inner medulla were separated for measurements of tissue
renin activity, ANG I, ANG II, and ANG 1–7 contents, and ACE and
ACE2 gene expression studies, respectively. Additional kidney tissues
from rats chronically infused with ANG II via SC minipumps (80
ng/min for 14 days; n  6) and sham-operated (n  5) were used to
examine ACE and ACE2 gene expression and functional enzymatic
activities.
Angiotensin peptides kidney content. Renal cortical and medullary
levels of ANG I, ANG II, and ANG 1–7 were extracted from kidney
sample homogenates, purified in Sep-Pak-C18 columns (Waters, Mil-
ford, MA), and measured by HPLC as previously described (1).
Peptides were identified according to retention time. The identity of
eluted ANG I, ANG II, and ANG 1–7 was confirmed by direct
sequencing (protein sequencer PPSQ-23; Shimadzu, Tokyo, Japan).
For concentration determination, commercially available peptides
were employed to develop a standard curve. Peptide levels were
normalized according to total protein concentration and results were
expressed as picograms per gram of protein.
ACE and ACE2 renal expression and functional activity. Twenty
nanograms per well of total RNA extracted from rat kidney cortex and
inner medulla samples were quantified by real-time qRT-PCR for
ACE and ACE2 mRNA levels, using protocols previously described
(28, 42). Data of quantitative qRT-PCR were normalized by -actin
mRNA expression. The sequences of primers and probes of ACE,
ACE2, and -actin are provided in the METHODS EXPANDED section (the
online version of this article contains supplemental data). For ACE2
immunoexpression, affinity-purified primary antibody against ACE2
(Dr. C. M. Ferrario; Wake Forest University, NC) was assessed by the
immunoperoxidase technique as previously described (44) at a dilu-
tion of 1:200 for ACE2. The ACE and ACE2 catalytic activities were
determined fluorimetrically by two different laboratories using either
the benzyloxycarbonyl-L-phenylalanyl-L-histidyl-L-leucine as a sub-
strate (5) with values reported in nanomoles per milligram of protein;
or the Fluorogenic Peptide Substrate VI [FPSVI, 7Mca-Y-V-A-D-A-
P-K(Dnp)-OH; R&D Systems, Minneapolis, MN] as previously de-
scribed (11) with values reported in reverse light units per milligram
of protein. Details of these protocols are provided in the METHODS
EXPANDED section.
Total renin, renin, and (pro)renin activities in kidney cortical and
medullary tissues. Active renin was determined as previously de-
scribed (56) by measuring the amount of ANG I generated per hour
from the renal tissue homogenates incubated at 37°C over a period of
24 h with the renin substrate tetradecapeptide (Sigma, St. Louis, MO)
and PMSF, as described in detail in the METHODS EXPANDED section.
Trypsinized tissue samples were also subjected to the above protocol
to determine total renin activity. (Pro)renin activity levels were
calculated as the difference between the total renin and the active
renin. The results are corrected by intracellular protein and expressed
as specific activity micrograms per microgram.
Statistical analyses. Results are presented as means  SE. Data
were evaluated by Grubb’s test (25) using GraphPad Software (San
Diego, CA) and analyzed when appropriate by unpaired Student’s
t-test or by one-way ANOVA with Dunnett’s Multiple Comparison
tests using GraphPad Prism Software, Version 5.0 for Windows
(GraphPad Software). A value of P  0.05 was regarded as signifi-
cant.
RESULTS
Table 1 shows the average body weights (BW), SBP, and
plasma renin activities (PRA) of rats subjected to sham oper-
ation or clipping of the left renal artery during the 25 days. In
2K1C rats, the BW was slightly lower than in sham rats after
7 days of surgery (251  5 vs. 236  5 g) and this trend
continued during the following 2 wk of the study (2K1C: 253 
6 g vs. sham: 280  4 g, after 14 days; and 2K1C: 291 
8 g vs. sham: 320  3 g, after 25 days; P  0.05). SBP values
were similar in both groups of rats at the beginning of the study
(2K1C: 126  2 vs. sham: 118  3 mmHg); however, after 1
wk following placement of the clip, the SBP was increased in
2K1C rats relative to sham-operated rats (2K1C: 154  5 vs.
129  4 mmHg) and continued to increase during the second
and third week following clipping (day 14  179  6 vs.
126  4 mmHg; day 25  183  6 vs. 125  4 mmHg; P 
0.001). At 25 days, PRA was elevated in 2K1C rats compared
with sham-operated rats (13.0  2 vs. 5.6  1 ng ANG
I·ml1·h1; P  0.05).
The concentrations of ANG I, ANG II, and ANG 1–7
measured in renal cortical and medullary homogenates after 3
wk of unilateral renal clipping from two independent studies
are shown in Fig. 1. Contents of all angiotensin peptides were
Table 1. Body wt, SBP, and PRA after 25 days of unilateral renal artery clipping
Body wt, g SBP, mmHg
Exp. group n Start End Baseline on day 1 25 days PRA, ng ANG I  ml1  h1
2K1C 11 186 6 291 8* 126 2 183 6* 13.0 2*
Sham 9 164 12 322 3 118 3 125 4 5.6 1
Values are means  SE. Comparisons of body wt, systolic blood pressure (SBP), and plasma renin activity (PRA) in sham-operated rats (n  9) and
two-kidney one-clip Goldblatt hypertensive (2K1C) rats (n  11). *P  0.05 Goldblatt rats vs. sham rats.
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higher in the renal medullary tissues than in the renal cortexes
of 2K1C rats. In the cortex, only the CK showed higher ANG
I and ANG II content than the sham kidney [ANG I (CK: 68
10; NCK: 51  8 vs. sham: 29  2 pg/g; P  0.05 CK vs.
sham); ANG II (CK: 129  17; NCK: 90  11 vs. sham 91 
15 pg/g; P 0.05 CK vs. sham)]. However, in the medulla, the
levels of ANG I and ANG II of both the CK and NCK kidneys
of 2K1C rats were significantly higher than in the sham kidneys
[ANG I (CK  171  4; NCK  251  8 vs. sham  55  3
pg/g protein; P  0.05 CK vs. sham, P  0.01 NCK
vs. sham); ANG II (CK  558  79; NCK  328  18 vs.
sham  94  7 pg/g protein); P  0.001 CK and NCK vs.
sham]. In contrast, the content of ANG 1–7 was substantially
lower in both the cortex and medulla of CK and NCK of 2K1C
rats [cortex: (CK  7  1; NCK  7  2 pg/g); medulla:
(CK  18  2; NCK  19  2 pg/g); P  0.05 kidney cortex
vs. kidney medulla] compared with sham rats [cortex: (36  6
pg/g); medulla (63  10 pg/g); P  0.001 vs. sham].
In the renal cortex of 2K1C rats, ACE mRNA levels were
increased in the CK but not in the NCK [ACE (CK: 1.6  0.4;
NCK: 1.0  0 vs. 1.0  0.0 AU; P  0.05)]; however, ACE2
transcript levels were similar between the CK and the NCK
[ACE2 (CK: 1.1  0.2; NCK: 0.7  0.2 vs. 1.0  0.0 AU)].
In contrast, in the renal medulla, ACE mRNA levels were
significantly increased in the CK and NCK of 2K1C rats
compared with sham rats (CK: 1.9  0.2; NCK: 1.6  0.1 vs.
1.0  0.1 AU; P  0.001), while the levels of ACE2 mRNA
levels were decreased (CK  0.5  0.1; NCK  0.3  0.1 vs.
1.0  0.1 AU; P  0.0001; Fig. 2). In addition, CK and NCK
compared with sham kidneys showed activities significantly
higher for ACE (CK: 7.5  1.0; NCK: 6.8  0.4 vs. 4.3  0.2
nmol/mg protein; P  0.05) but decreased for ACE2 (CK:
0.9  0.2; NCK: 0.8  0.1 vs. 1.5  0.1 nmol/mg protein;
P  0.05).
To further validate the reciprocal changes in ACE and
ACE2, we examined the mRNA abundance of ACE and ACE2,
as well as their functional activities in kidney tissues from
chronic ANG II-infused (n  6) rats and sham-operated rats
(n 5). In these rats, although the ACE mRNA levels were not
significantly different between the two groups, the ANG II rats
exhibited substantially greater ACE activity in the kidneys than
the control rats (ANG II  2,712  334 vs. sham  487  51
RLU/mg; P  0.05). In addition, the ACE2 transcript levels
were reduced in chronic ANG II-infused rats (ANG II 0.6
0.1 vs. sham  1.0  0.0 AU; P  0.05) but we did find any
difference in its activity (ANG II  2,356  786 vs. sham 
1,290  225 RLU/mg) compared with sham rats.
Figure 3 depicts the specific immunoreactivity and semi-
quantitation for ACE2 immunostaining by using the immuno-
peroxidase technique on a kidney section from sham-operated
(top panels); clipped and nonclipped kidneys of 2K1C rats
(middle panels) and ANG II-infused rats (bottom panels).
ACE2 immunoreactivity was predominantly observed in the
cytoplasm of epithelial cells of PTs in the cortex and inner
cortex (left panels) and to a lesser extent in the CD cells of the
inner medulla.
Figure 4 reflects the specific renin activity measured as ANG
I generated per hour over a period of 24 h from the time the
tetradecapeptide was added and corrected by total protein in
the tissue kidney lysates. Between 2 and 8 h of incubation with
the tetradecapeptide, the specific activity of renin was signifi-
cantly higher in the cortex of CK than in the cortex of NCK or
sham kidneys. However, in the renal medullary tissues during
the same period, the renin activities in both the CK and NCK
were higher than in sham kidneys. By 12–14 h later, renin
activities became comparable between the CK and the sham
kidney. In addition, the incubation with the tetradecapeptide in
the presence of trypsin showed that in the renal cortex, the
maximum (pro)renin activity observed at 2 h was significantly
higher in the CK, while in the renal medulla, the NCK
exhibited greater (pro)renin activity.
Fig. 2. Comparison of angiotensin-converting enzyme (ACE) and ACE2
mRNA expression levels in rat renal cortex and medulla tissues. Quantification
of mRNA levels was measured by real-time qRT-PCR in CK and NCK
kidneys of Goldblatt (n  11) rats and compared with sham-operated (n  9)
rats. The mRNA levels for the target genes were determined in each sample per
triplicate and expressed as a ratio relative to -actin. Values are means  SE.
*P  0.05, **P  0.001, ***P  0.0001 vs. sham kidney.
Fig. 1. Angiotensin peptide contents in rat kidney cortex and medulla. The
levels of ANG I, ANG II, and ANG 1–7 were measured by HPLC in kidney
cortex and medulla samples from Goldblatt (n  11) rats and sham (n  9)
rats. Values are expressed in pg/g of protein. Values are means  SE. *P 
0.05, **P 0.01, ***P 0.001 vs. sham. #P 0.05 kidney cortex vs. kidney
medulla. #P  0.05 clipped (CK) vs. nonclipped (NCK).
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DISCUSSION
The present study demonstrates that both kidneys of 2K1C
hypertensive rats exhibit reciprocal changes in ANG II/ACE
and ANG 1–7/ACE2 in association with an enhancement of
CD renin activity. This observation provides the basis for an
additional mechanism that may contribute to explain high
intrarenal ANG II content in the kidneys during Goldblatt
hypertension. In a previous study, we demonstrated that in
2K1C hypertensive rats evaluated after 25 days of unilateral
renal artery clipping, there is an increased renin immunostain-
ing in cortical and medullary CD cells accompanied by aug-
mented renin mRNA and protein levels in the renal medullary
tissues (44). The present study extends those observations by
confirming that in the renal medullary regions of both kidneys
of 2K1C rats, most of the renin present is active. In contrast, in
the renal cortical region only the CK exhibits higher renin
activity (Fig. 4). Thus, it is likely that the enhancement of renin
activity in the renal medulla of 2K1C rats may contribute to
increased intrarenal ANG I and ultimately ANG II content
regardless of the suppression of JG renin such as occurs in the
NCK of this experimental model of hypertension.
Compared with other organs, the kidney expresses relatively
high levels of ACE2. In the rat kidney, mRNA for ACE2 has
been detected in all nephron segments including PTs, CDs, and
vasa recta (3, 33, 54). Although ACE2 was first shown to
cleave ANG I to ANG 1–9 (10), subsequent studies revealed
that this enzyme exhibits a greater catalytic activity for ANG II
than ANG I (55). The consequences of intrarenal ACE2-
mediated formation of ANG 1–7 from ANG II remain unclear.
Evidence suggests that ANG 1–7 exerts a countering influence
against ANG II, which could partially protect against the
development of hypertension (2, 14, 16, 23, 34, 46). Recent
studies demonstrated that ANG II downregulates ACE2
mRNA expression in the heart, kidney, and astrocytes (17–19).
Furthermore, it has been suggested that ANG II downregulates
ACE2 via the AT1R-ERK/p38 MAP kinase pathway (31).
Chappell and Ferrario (7) reported pronounced increases in
ACE2 transcript levels within the kidney of the normotensive
Lewis and hypertensive mRen2.Lewis rats following ARB
treatment with losartan. In the present study, we show that both
the CK and the NCK medullary tissues exhibit decreased
ACE2 immunoreactivity, activity, and transcript levels com-
pared with kidneys from sham-operated rats. Reduced levels of
ACE2 gene expression and activity are consistent also with our
finding of decreased levels of ANG 1–7 content in the renal
medulla of CK and NCK of 2K1C hypertensive rats. The
observation of increased ANG I and ANG II contents in the renal
medulla of both kidneys of 2K1C rats, along with the previous
demonstration that levels of renin mRNA and protein as well as
its activity are augmented in these tissues (44), suggests that
the upregulation of CD renin may contribute to the increases in
intrarenal ANG II content.
In the 2K1C Goldblatt hypertension model during the initial
phase of hypertension, there are ANG II-dependent alterations
in tubular reabsorption of the NCK due to the elevations in
circulating and intrarenal ANG II levels (9, 21, 41). Accumu-
lated evidence indicates that there is enough ACE activity in
the CDs (4, 45) that may lead to intraluminal conversion of
ANG I to ANG II in this part of the nephron (32) and
contribute to the ANG II stimulation of epithelial sodium
Fig. 3. Immunohistochemistry of ACE2 using
immunoperoxidase technique on 3-m paraf-
fin-embedded cortex and medulla kidney sec-
tions from sham, 2K1C, and chronic ANG
II-infused rats. Panels show, respectively,
cortical and medullary regions with specific
ACE2 immunostaining in sham rats (top pan-
els), 2K1C Goldblatt (CK and NCK; middle
panels), and ANG II-infused rats (bottom pan-
els). *P  0.05 and **P  0.001 vs. sham.
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channel activity at the surface of the CD cells (40). In the
present study, we found that in the renal cortical regions, ACE
transcript levels are augmented only in the CK while in the
renal medulla, ACE mRNA levels and its activity are aug-
mented in both kidneys of 2K1C hypertensive rats. Guan et al.
(21) suggested that the de novo formation of intrarenal ANG II
in the NCK of 2K1C rats is partially due to augmented
intrarenal ACE activity (21) and our current data support this
notion. In the chronic ANG II-infused rat model, it has also
been reported that augmentation of intrarenal ANG II content
is likely related to an increase in intrarenal ACE protein since
Harrison-Bernard et al. (24) observed an increase in ACE
immunostaining in PTs; and Sadjadi et al. (50) reported in-
creased renal ACE activity despite no changes in plasma ACE
activity. Using the chronic ANG II hypertensive rat model, we
found that, although renal ACE mRNA levels did not differ
from those in sham rats, the ACE activity was also significantly
augmented in the ANG II-infused rats. This is consistent with
the report showing that changes in enzymatic activity may
occur without transcriptional and/or posttranslational altera-
tions; i.e., by changing the open structure of the specific protein
conformation (26).
It has been suggested that ACE2 is the major enzyme
involved in ANG 1–7 formation from ANG II in tissues; thus
contributing to ANG II degradation (8, 60). Our data demon-
strating reduced ACE2 mRNA levels and activity in both
kidneys of Goldblatt hypertensive rats as well as decreased
specific immunoreactivity of ACE2 in the kidneys of chronic
ANG II-infused rats support a functional role for ACE2 to
contribute to the increases of intrarenal ANG II content by
reducing the ACE2-mediated degradation of ANG II. The
collective effect of increased ACE leading to increased ANG II
formation, coupled with decreased ACE2, diminishing ANG II
degradation to ANG 1–7, would be to increase prevailing
levels of ANG II, as well as reduce ANG 1–7 levels. These
observations do not mean that this is the only mechanism
responsible for the reciprocal changes in intrarenal ANG II/
ANG 1–7 contents during ANG II-dependent hypertension. In
this regard, it has been reported that augmentation of chymase
activity in the ischemic kidney of 2K1C rats (49) and in
Fig. 4. Curves of specific enzymatic activity of total
renin, free renin, and (pro)renin in cortical and
medullary tissues of both kidneys from 2K1C rats.
Enzymatic activity was measured in the presence
and absence of trypsin over a period of 24-h incu-
bation with excess of renin substrate. Values were
determined from the amount of ANG I (g) product
measured by HPLC per g of tissue protein and
expressed as means  SE. *P  0.05 sham kidneys
vs. clipped kidneys. #P  0.05 sham kidneys vs.
nonclipped kidneys.
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diabetic renal vascular disease (39) is also a mechanism re-
sponsible for ACE-independent intrarenal ANG II production.
The augmentation of renin activity in distal nephron segments
along with increases in medullary ANG I content of both
kidneys of 2K1C rats support the notion of increased intrarenal
ANG II formation, which ultimately may stimulate sodium
reabsorption in the CD and may explain the attenuation of the
pressure natriuretic response to elevations in arterial blood
pressure and the development and maintenance of hypertension
in Goldblatt hypertensive rats. Therefore, the synergistic ac-
tions of distal nephron renin-mediated increases of ANG II,
along with the diminished counteracting influence of ANG 1–7
associated with the direct effects of ANG II on distal nephron
transport mechanisms could provide a powerful sodium-retain-
ing stimulus in Goldblatt hypertension (2, 36, 38), thereby
allowing for a greater influence in the progression of high
blood pressure in the 2K1C hypertensive rats.
In summary, the present findings indicate that the upregula-
tion of CD renin in the renal medulla of both CK and NCK of
2K1C rats is associated with reciprocal changes in the ANG II
and ANG 1–7 contents in the medullary regions of the kidneys
of these rats. During conditions of RAS activation, subsequent
to clipping one of the renal arteries or during chronic ANG II
infusion, there are increases in CD renin activity coupled with
substantial decreases of ANG 1–7 content and ACE2 and
increases in ANG II and ACE; which may contribute to the
progression of high blood pressure during ANG II-dependent
hypertension.
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